Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PaTS-COVID: Ivermectin and Aspirin for COVID-19 Pneumonia
NCT04703608Phase 3Unknown
- Sponsor
- London School of Hygiene & Tropical Medicine
- Start
- Jan 2021
- Primary completion
- Mar 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of ivermectin, aspirin in coronavirus disease 2019 (COVID-19), sponsored by London School of Hygiene & Tropical Medicine. Status: unknown.
02
Drugs
ivermectinaspirin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04703608.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04703608.